DALLAS, Nov 14 (Bernama-BUSINESS WIRE) — The Mary Kay Ash Foundation®, a champion of women’s health innovation for nearly three decades, announced a $500,000 grant to Baylor Scott & White Dallas Foundation to accelerate a pioneering triple-negative breast cancer clinical trial and advance early detection initiatives that shift care from reactive to proactive at the newly established Texas Cancer Interception Institute.
The two-fold grant includes:
- $100,000 in continued support of a forward-thinking TRIM-EBC Clinical Trial led by world renowned Celebrating Women chair for Breast Cancer Research, Joyce O’Shaughnessy, MD. The trial explores the potential of weight-loss medications to reduce recurrence risk in overweight breast cancer patients.
https://mrem.bernama.com/viewsm.php?idm=52771